From: Case study: biosimilar anti TNFalpha (Adalimumab) analysis of Fc effector functions
Assay
Originator
Relative potency
CV
ADCC
2
140%
9.9%
3
141%
11.1%
4
135%
16.8%
CDC
92%
15.1%
89%
10.2%
16.7%